ArriVent BioPharma, Inc. announces its Q3 2026 results, detailing financial metrics and performance in the pharmaceutical preparations sector.
| Name | ArriVent BioPharma, Inc. |
|---|---|
| CIK | 0001868279 |
| Tickers | AVBP |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 240-780-6356 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
ArriVent BioPharma, Inc. announces its Q3 2026 results, detailing financial metrics and performance in the pharmaceutical preparations sector.
FMR LLC has raised its ownership in ArriVent BioPharma to 5.8%, signaling increased institutional interest in the pharmaceutical preparations sector.
ArriVent BioPharma announces promising Phase 1 data for ARR-217, a potential treatment for gastrointestinal cancers, at ESMO Congress 2026.
ArriVent BioPharma reveals promising Phase 1b results for firmonertinib, targeting EGFR PACC-mutant non-small cell lung cancer.
ArriVent BioPharma's Phase 3 FURVENT trial of firmonertinib did not meet its primary endpoint, prompting a reevaluation of its development path.
162 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-09 | 10-Q | 10-Q | 0001104659-26-124513 | 001-41929 | 261536277 | 34 | 6655375 | 1 | 1 | |
| 2026-11-09 | 8-K | FORM 8-K | 2.02,5.02,9.01 | 0001104659-26-124484 | 001-41929 | 261535891 | 34 | 306893 | 1 | 1 |
| 2026-11-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002691 | 005-94331 | 261526083 | 34 | 11656 | |||
| 2026-11-02 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-121410 | 24162 | ||||||
| 2026-10-26 | 8-K | FORM 8-K | 7.01,8.01,9.01 | 0001104659-26-118550 | 001-41929 | 261483366 | 34 | 220565 | 1 | 1 |
| 2026-10-19 | 8-K | FORM 8-K | 7.01,9.01 | 0001104659-26-116736 | 001-41929 | 261467559 | 34 | 220979 | 1 | 1 |
| 2026-10-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001213900-26-109019 | 005-94331 | 261456860 | 34 | 25442 | |||
| 2026-10-13 | 8-K | FORM 8-K | 7.01,8.01,9.01 | 0001104659-26-115161 | 001-41929 | 261454290 | 34 | 210618 | 1 | 1 |
| 2026-10-08 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0000947871-26-000931 | 005-94331 | 261450814 | 34 | 33838 | |||
| 2026-10-06 | 8-K | FORM 8-K | 7.01,8.01,9.01 | 0001104659-26-113898 | 001-41929 | 261442341 | 34 | 229550 | 1 | 1 |
| 2026-08-12 | 10-Q | 10-Q | 0001104659-26-094902 | 001-41929 | 261267807 | 34 | 6056079 | 1 | 1 | |
| 2026-08-12 | 8-K | FORM 8-K | 1.01,2.02,9.01 | 0001104659-26-094869 | 001-41929 | 261267499 | 34 | 305460 | 1 | 1 |
| 2026-07-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-002185 | 005-94331 | 261206121 | 34 | 11127 | |||
| 2026-06-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-076570 | 5781 | ||||||
| 2026-06-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-076569 | 5839 | ||||||
| 2026-06-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-076567 | 5832 | ||||||
| 2026-06-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-076566 | 5815 | ||||||
| 2026-06-22 | 8-K | FORM 8-K | 5.07 | 0001104659-26-076352 | 001-41929 | 261106928 | 34 | 200525 | 1 | 1 |
| 2026-05-11 | 8-K | FORM 8-K | 8.01,9.01 | 0001104659-26-058706 | 001-41929 | 26963973 | 34 | 222206 | 1 | 1 |
| 2026-05-11 | 424B5 | 424B5 | 0001104659-26-058700 | 333-284661 | 26963936 | 33 | 652535 | 1 | 1 | |
| 2026-05-11 | 10-Q | 10-Q | 0001104659-26-058650 | 001-41929 | 26963238 | 34 | 5420785 | 1 | 1 | |
| 2026-05-11 | 8-K | 8-K | 2.02,9.01 | 0001104659-26-058638 | 001-41929 | 26963147 | 34 | 336151 | 1 | 1 |
| 2026-05-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-001106 | 005-94331 | 26946568 | 34 | 11391 | |||
| 2026-04-28 | ARS | ARS | 0001104659-26-050350 | 001-41929 | 26907924 | 34 | 4673742 | |||
| 2026-04-28 | DEFA14A | DEFA14A | 0001104659-26-050344 | 001-41929 | 26907819 | 34 | 321591 | |||
| 2026-04-28 | DEF 14A | FORM- DEF 14A | 0001104659-26-050337 | 001-41929 | 26907738 | 34 | 1871887 | 1 | 1 | |
| 2026-03-17 | 8-K | 8-K | 7.01,8.01,9.01 | 0001104659-26-029588 | 001-41929 | 26763228 | 34 | 194203 | 1 | 1 |
| 2026-03-05 | S-8 | FORM S-8 | 0001104659-26-024136 | 333-294056 | 26726481 | 33 | 195276 | 1 | 1 | |
| 2026-03-05 | 10-K | 10-K | 0001104659-26-024127 | 001-41929 | 26726381 | 34 | 13580795 | 1 | 1 | |
| 2026-03-05 | 8-K | 8-K | 2.02,9.01 | 0001104659-26-024112 | 001-41929 | 26726227 | 34 | 318909 | 1 | 1 |
| 2026-03-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-26-023750 | 005-94331 | 26724084 | 34 | 29253 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002058093-26-000004 | 005-94331 | 26642411 | 34 | 9468 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-26-001013 | 005-94331 | 26636909 | 34 | 8958 | |||
| 2026-02-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-010478 | 5695 | ||||||
| 2026-02-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-010477 | 5686 | ||||||
| 2026-02-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-010473 | 5701 | ||||||
| 2026-02-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-010472 | 5650 | ||||||
| 2026-02-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-010471 | 5671 | ||||||
| 2026-02-03 | 4 | xslF345X05/ownership.xml | 0000902664-26-000675 | 9801 | ||||||
| 2026-01-30 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000102909-26-000090 | 005-94331 | 26581903 | 34 | 7186 | |||
| 2026-01-21 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-26-000643 | 005-94331 | 26545829 | 34 | 10985 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001214659-25-016716 | 005-94331 | 251487627 | 34 | 14151 | |||
| 2025-11-10 | 10-Q | 10-Q | 0001104659-25-108847 | 001-41929 | 251464434 | 34 | 6141860 | 1 | 1 | |
| 2025-11-10 | 8-K | 8-K | 2.02,9.01 | 0001104659-25-108839 | 001-41929 | 251464408 | 34 | 361364 | 1 | 1 |
| 2025-11-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-002677 | 005-94331 | 251452567 | 34 | 11701 | |||
| 2025-10-30 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000102909-25-000025 | 005-94331 | 251433979 | 34 | 6283 | |||
| 2025-10-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-25-002500 | 005-94331 | 251401780 | 34 | 11038 | |||
| 2025-10-15 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-099728 | 005-94331 | 251394897 | 34 | 7887 | |||
| 2025-09-09 | 8-K | 8-K | 7.01,8.01,9.01 | 0001558370-25-011954 | 001-41929 | 251301691 | 34 | 200993 | 1 | 1 |
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-021943 | 005-94331 | 251220640 | 34 | 7597 | |||
| 2025-08-13 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000947871-25-000764 | 005-94331 | 251213647 | 34 | 33755 | |||
| 2025-08-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000919574-25-004712 | 005-94331 | 251213611 | 34 | 17209 | |||
| 2025-08-13 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002058093-25-000008 | 005-94331 | 251213315 | 34 | 9906 | |||
| 2025-08-11 | 10-Q | 10-Q | 0001558370-25-010975 | 001-41929 | 251200250 | 34 | 6489197 | 1 | 1 | |
| 2025-08-11 | 8-K | 8-K | 2.02,9.01 | 0001558370-25-010974 | 001-41929 | 251200243 | 34 | 367122 | 1 | 1 |
| 2025-07-21 | 8-K | FORM 8-K | 8.01,9.01 | 0001104659-25-069169 | 001-41929 | 251135757 | 34 | 216348 | 1 | 1 |
| 2025-07-15 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-067928 | 15780 | ||||||
| 2025-07-02 | 424B5 | 424B5 | 0001104659-25-065391 | 333-284661 | 251102323 | 33 | 636707 | |||
| 2025-07-02 | 8-K | FORM 8-K | 1.01,8.01,9.01 | 0001104659-25-065386 | 001-41929 | 251102276 | 34 | 738275 | 1 | 1 |
| 2025-07-01 | 424B5 | 424B5 | 0001104659-25-064736 | 333-284661 | 251096500 | 33 | 607094 | |||
| 2025-06-23 | 8-K | FORM 8-K | 7.01,8.01,9.01 | 0001104659-25-061375 | 001-41929 | 251062954 | 34 | 241188 | 1 | 1 |
| 2025-06-20 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-061270 | 5357 | ||||||
| 2025-06-20 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-061269 | 5418 | ||||||
| 2025-06-20 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-061268 | 5411 | ||||||
| 2025-06-20 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-061267 | 5394 | ||||||
| 2025-06-20 | 8-K | FORM 8-K | 5.07 | 0001104659-25-061165 | 001-41929 | 251061510 | 34 | 198878 | 1 | 1 |
| 2025-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002058093-25-000002 | 005-94331 | 25954390 | 34 | 9703 | |||
| 2025-05-12 | 10-Q | 10-Q | 0001558370-25-007276 | 001-41929 | 25932935 | 34 | 6076466 | 1 | 1 | |
| 2025-05-12 | 8-K | 8-K | 2.02,9.01 | 0001558370-25-007259 | 001-41929 | 25932660 | 34 | 339740 | 1 | 1 |
| 2025-04-29 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-041344 | 5563 | ||||||
| 2025-04-29 | 3 | OWNERSHIP DOCUMENT | 0001104659-25-041340 | 12313 | ||||||
| 2025-04-28 | ARS | ARS | 0001104659-25-040239 | 001-41929 | 25880855 | 34 | 4497531 | |||
| 2025-04-28 | DEFA14A | DEFA14A | 0001104659-25-040227 | 001-41929 | 25880671 | 34 | 319352 | |||
| 2025-04-28 | DEF 14A | DEF 14A | 0001104659-25-040214 | 001-41929 | 25880588 | 34 | 1895969 | 1 | 1 | |
| 2025-04-28 | 8-K | FORM 8-K | 5.02,7.01,9.01 | 0001104659-25-039799 | 001-41929 | 25876032 | 34 | 238849 | 1 | 1 |
| 2025-03-13 | 8-K | 8-K | 4.01,9.01 | 0001558370-25-002912 | 001-41929 | 25736665 | 34 | 173707 | 1 | 1 |
| 2025-03-03 | S-8 | FORM S-8 | 0001104659-25-019484 | 333-285480 | 25693784 | 33 | 94274 | |||
| 2025-03-03 | 8-K | 8-K | 2.02,9.01 | 0001558370-25-002002 | 001-41929 | 25693776 | 34 | 341139 | 1 | 1 |
| 2025-03-03 | 10-K | 10-K | 0001558370-25-001999 | 001-41929 | 25693768 | 34 | 13029776 | 1 | 1 | |
| 2025-02-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-021707 | 005-94331 | 25632195 | 34 | 7366 | |||
| 2025-02-14 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-014175 | 5657 | ||||||
| 2025-02-14 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-014172 | 5693 | ||||||
| 2025-02-14 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-014170 | 5702 | ||||||
| 2025-02-14 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-014164 | 5708 | ||||||
| 2025-02-14 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-014160 | 5678 | ||||||
| 2025-02-03 | S-3ASR | S-3ASR | 0001104659-25-008356 | 333-284661 | 25580581 | 33 | 1678128 | |||
| 2025-01-22 | 8-K | FORM 8-K | 1.01,7.01,9.01 | 0001104659-25-004967 | 001-41929 | 25543611 | 34 | 227402 | 1 | 1 |
| 2024-12-04 | SC 13G | d11538049_13g.htm | 0000919574-24-007004 | 005-94331 | 241526622 | 34 | 108267 | |||
| 2024-11-14 | SC 13G | ARRIVENT BIOPHARMA, INC. | 0000902664-24-006621 | 005-94331 | 241463315 | 34 | 60001 | |||
| 2024-11-14 | 10-Q | 10-Q | 0001558370-24-015624 | 001-41929 | 241457295 | 34 | 5606576 | 1 | 1 | |
| 2024-11-14 | 8-K | 8-K | 2.02,9.01 | 0001558370-24-015622 | 001-41929 | 241457279 | 34 | 319612 | 1 | 1 |
| 2024-11-12 | SC 13G | SC 13G | 0001104659-24-116708 | 005-94331 | 241447136 | 34 | 117818 | |||
| 2024-11-12 | SC 13G | filing.txt | 0000315066-24-002662 | 005-94331 | 241444451 | 34 | 8307 | |||
| 2024-11-08 | SC 13G | us04272n1028_110824.txt | 0002012383-24-003521 | 005-94331 | 241439669 | 34 | 13776 | |||
| 2024-10-24 | SC 13G | us04272n1028_102424.txt | 0002012383-24-002199 | 005-94331 | 241392066 | 34 | 13764 | |||
| 2024-10-11 | SC 13G | avbp1011241sc13g.htm | 0001214659-24-017477 | 005-94331 | 241367544 | 34 | 91215 | |||
| 2024-09-23 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-102146 | 23533 | ||||||
| 2024-09-09 | 8-K | FORM 8-K | 7.01,8.01,9.01 | 0001104659-24-098059 | 001-41929 | 241286528 | 34 | 237924 | 1 | 1 |
| 2024-08-14 | 10-Q | 10-Q | 0001558370-24-012236 | 001-41929 | 241208059 | 34 | 5669032 | 1 | 1 | |
| 2024-08-14 | 8-K | 8-K | 2.02,9.01 | 0001558370-24-012223 | 001-41929 | 241207468 | 34 | 373987 | 1 | 1 |
| 2024-07-09 | 8-K/A | 8-K/A | 5.02 | 0001104659-24-078587 | 001-41929 | 241108038 | 34 | 203632 | 1 | 1 |
| 2024-07-09 | 8-K/A | FORM 8-K/A | 5.02,9.01 | 0001104659-24-078585 | 001-41929 | 241108013 | 34 | 231668 | 1 | 1 |
| 2024-06-05 | 8-K | FORM 8-K | 1.01,7.01,9.01 | 0001104659-24-068503 | 001-41929 | 241020711 | 34 | 228595 | 1 | 1 |
| 2024-05-20 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-063518 | 5624 | ||||||
| 2024-05-20 | 3 | OWNERSHIP DOCUMENT | 0001104659-24-063516 | 11871 | ||||||
| 2024-05-16 | 8-K | FORM 8-K | 5.02,9.01 | 0001104659-24-062528 | 001-41929 | 24955661 | 34 | 238788 | 1 | 1 |
| 2024-05-08 | 10-Q | 10-Q | 0001558370-24-007197 | 001-41929 | 24924309 | 34 | 4412821 | 1 | 1 | |
| 2024-05-08 | 8-K | 8-K | 2.02,9.01 | 0001558370-24-007196 | 001-41929 | 24924295 | 34 | 340799 | 1 | 1 |
| 2024-04-23 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-050577 | 5626 | ||||||
| 2024-04-23 | 3 | OWNERSHIP DOCUMENT | 0001104659-24-050572 | 3246 | ||||||
| 2024-04-22 | 8-K | FORM 8-K | 5.02,9.01 | 0001104659-24-049988 | 001-41929 | 24861289 | 34 | 226052 | 1 | 1 |
| 2024-03-28 | 10-K | 10-K | 0001558370-24-004280 | 001-41929 | 24800339 | 34 | 4396641 | |||
| 2024-03-28 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-24-040532 | 001-41929 | 24799119 | 34 | 286069 | 1 | 1 |
| 2024-02-13 | SC 13G | SCHEDULE 13G | 0001213900-24-013438 | 005-94331 | 24630068 | 34 | 128478 | |||
| 2024-02-05 | SC 13D | SCHEDULE 13D | 0000947871-24-000091 | 005-94331 | 24596387 | 34 | 182637 | |||
| 2024-02-02 | S-8 | FORM S-8 | 0001104659-24-010025 | 333-276840 | 24591439 | 33 | 121962 | |||
| 2024-02-01 | 4 | xslF345X05/ownership.xml | 0000902664-24-000903 | 18415 | ||||||
| 2024-01-31 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-008799 | 31078 | ||||||
| 2024-01-31 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-008797 | 25562 | ||||||
| 2024-01-31 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-008796 | 10096 | ||||||
| 2024-01-30 | 8-K | FORM 8-K | 5.03,8.01,9.01 | 0001104659-24-008228 | 001-41929 | 24578163 | 34 | 418416 | 1 | 1 |
| 2024-01-29 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-007733 | 5500 | ||||||
| 2024-01-29 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-007732 | 5465 | ||||||
| 2024-01-26 | SEC STAFF LETTER | filename1.pdf | 9999999997-24-000221 | 63823 | ||||||
| 2024-01-26 | 424B4 | 424B4 | 0001104659-24-007261 | 333-276397 | 24567874 | 33 | 5681668 | |||
| 2024-01-25 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2024-01-25 17:00:00 | 9999999995-24-000212 | 333-276397 | 24563985 | 33 | 1776 | ||
| 2024-01-25 | 3 | xslF345X02/ownership.xml | 0000902664-24-000669 | 8067 | ||||||
| 2024-01-25 | 3 | OWNERSHIP DOCUMENT | 0001104659-24-006839 | 16674 | ||||||
| 2024-01-25 | 3 | OWNERSHIP DOCUMENT | 0001104659-24-006838 | 20519 | ||||||
| 2024-01-25 | 3 | OWNERSHIP DOCUMENT | 0001104659-24-006837 | 13186 | ||||||
| 2024-01-25 | 3 | OWNERSHIP DOCUMENT | 0001104659-24-006835 | 19117 | ||||||
| 2024-01-25 | 3 | OWNERSHIP DOCUMENT | 0001104659-24-006834 | 21496 | ||||||
| 2024-01-25 | 3 | OWNERSHIP DOCUMENT | 0001104659-24-006833 | 13149 | ||||||
| 2024-01-25 | 3 | OWNERSHIP DOCUMENT | 0001104659-24-006832 | 15586 | ||||||
| 2024-01-25 | 3 | OWNERSHIP DOCUMENT | 0001104659-24-006831 | 14041 | ||||||
| 2024-01-25 | 3 | OWNERSHIP DOCUMENT | 0001104659-24-006828 | 19263 | ||||||
| 2024-01-25 | 3 | OWNERSHIP DOCUMENT | 0001104659-24-006827 | 14542 | ||||||
| 2024-01-25 | S-1MEF | S-1MEF | 0001104659-24-006807 | 333-276699 | 24563670 | 33 | 77944 | |||
| 2024-01-25 | CERT | 8A_cert_AVBP.pdf | 0001354457-24-000034 | 001-41929 | 24560589 | 34 | 154473 | |||
| 2024-01-23 | S-1/A | S-1/A | 0001104659-24-005933 | 333-276397 | 24553506 | 33 | 5813990 | |||
| 2024-01-23 | 8-A12B | 8-A12B | 0001104659-24-005880 | 001-41929 | 24552573 | 34 | 14567 | |||
| 2024-01-23 | CORRESP | filename1.htm | 0001104659-24-005879 | 13177 | ||||||
| 2024-01-23 | CORRESP | filename1.htm | 0001104659-24-005876 | 9289 | ||||||
| 2024-01-22 | CORRESP | filename1.htm | 0001104659-24-005370 | 21022 | ||||||
| 2024-01-22 | S-1/A | S-1/A | 0001104659-24-005364 | 333-276397 | 24547042 | 33 | 6342885 | |||
| 2024-01-12 | UPLOAD | filename1.pdf | 0000000000-24-000472 | 377-06842 | 44422 | |||||
| 2024-01-11 | CORRESP | filename1.htm | 0001104659-24-003272 | 116488 | ||||||
| 2024-01-05 | S-1 | S-1 | 0001104659-24-001804 | 333-276397 | 24516457 | 33 | 9161918 | |||
| 2023-12-06 | DRS/A | filename1.htm | 0001104659-23-123723 | 377-06842 | 231468242 | 33 | 7038914 | |||
| 2023-12-05 | DRSLTR | filename1.htm | 0001104659-23-123726 | 25813 | ||||||
| 2023-11-15 | UPLOAD | filename1.pdf | 0000000000-23-012534 | 377-06842 | 47864 | |||||
| 2023-10-31 | DRSLTR | filename1.htm | 0001104659-23-113011 | 60311 | ||||||
| 2023-10-31 | DRS/A | filename1.htm | 0001104659-23-113008 | 377-06842 | 231365749 | 33 | 7022904 | |||
| 2023-10-18 | UPLOAD | filename1.pdf | 0000000000-23-011405 | 377-06842 | 65321 | |||||
| 2023-10-13 | SEC STAFF LETTER | filename1.pdf | 9999999997-23-004535 | 64923 | ||||||
| 2023-10-04 | DRSLTR | filename1.htm | 0001104659-23-106887 | 115178 | ||||||
| 2023-10-04 | DRS/A | filename1.htm | 0001104659-23-106884 | 377-06842 | 231308935 | 33 | 6353822 | |||
| 2023-09-27 | UPLOAD | filename1.pdf | 0000000000-23-010683 | 377-06842 | 80568 | |||||
| 2023-08-25 | DRS | filename1.htm | 0001104659-23-095379 | 377-06842 | 231209007 | 33 | 9779368 | |||
| 2022-12-29 | D | xslFormDX01/primary_doc.xml | 06b | 0001868279-22-000002 | 021-469072 | 221497473 | 33 | 11031 | ||
| 2022-02-14 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001868279-22-000001 | 021-403969 | 22629931 | 33 | 8441 | ||
| 2021-06-23 | D | xslFormDX01/primary_doc.xml | 06b | 0001868279-21-000002 | 021-403969 | 211038894 | 33 | 5927 |
One latest value per concept from companyfacts (163 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 51.72M | 2026-11-05 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 762.66M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 34,525 | 2026-05-11 | 424B5 | 2026-05-11 | 0001104659-26-058700 | |||
| ffd | NrrtvMaxAggtOfferingPric | NrrtvMaxAggtOfferingPric | USD | 250.00M | 2026-05-11 | 424B5 | 2026-05-11 | 0001104659-26-058700 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 34,525 | 2026-05-11 | 424B5 | 2026-05-11 | 0001104659-26-058700 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 250.00M | 2026-05-11 | 424B5 | 2026-05-11 | 0001104659-26-058700 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-05-11 | 424B5 | 2026-05-11 | 0001104659-26-058700 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-05-11 | 424B5 | 2026-05-11 | 0001104659-26-058700 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 2.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 20.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 630,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -466,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 932.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 6.88M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 1.57M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 19.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 4.33M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | Assets | Assets | USD | 417.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 416.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 194,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 468,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value | USD | 264.30M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-11 | 0001104659-26-058650 | |
| us-gaap | Cash | Cash | USD | 2.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 113.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 113.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 68.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 40.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 1.31M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-11 | 0001104659-26-058650 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 200.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 51.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 51.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 5,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -134.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | DeferredCosts | Deferred Costs, Noncurrent | USD | 38,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 39,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 19.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 109.27M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 39,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 34.28M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 2.64M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 9.05M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 109.27M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 | |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 700,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercent | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay | pure | 0.04 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercentOfMatch | Defined Contribution Plan, Employer Matching Contribution, Percent of Match | pure | 1 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | DepreciationAmortizationAndAccretionNet | Depreciation, Amortization and Accretion, Net | USD | -1.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -2.82 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -2.82 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.215 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | -0.008 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.006 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.001 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0001558370-25-001999 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.049 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0.011 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 4.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 72.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | FinancingReceivableAllowanceForCreditLosses | Financing Receivable, Allowance for Credit Loss | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 28.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 35.84M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -34.93M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 1.08M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | -1.99M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | IncreaseDecreaseInAccountsPayableTrade | Increase (Decrease) in Accounts Payable, Trade | USD | -3.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 745,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -48,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | -87,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 3.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 10.75M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0001558370-24-015624 |
| us-gaap | InvestmentIncomeNet | Investment Income, Net | USD | 8.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 14,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 14,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 14,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0001558370-25-001999 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 42,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0001558370-24-015624 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 11,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0001558370-25-001999 | |
| us-gaap | Liabilities | Liabilities | USD | 23.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 417.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 27.84M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001104659-26-094902 | |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 47.68M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 201.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -11.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -122.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -133.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -133.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -133.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 147.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -142.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 200,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 14,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 256,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 33,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001104659-26-094902 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 302,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.1 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 18,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 134,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -480,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -480,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 2.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | PaymentsForRent | Payments for Rent | USD | 200,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 53,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 204.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | PaymentsToAcquireShortTermInvestments | Payments to Acquire Short-term Investments | USD | 194.16M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0001558370-25-001999 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | PreferredStockValueOutstanding | Preferred Stock, Value, Outstanding | USD | 0 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-08 | 0001558370-24-007197 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 23.39M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 407,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 185.95M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0001558370-25-001999 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 199.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 44.92M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0001558370-25-001999 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments | Proceeds from Maturities, Prepayments and Calls of Short-term Investments | USD | 1.70M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0001558370-25-001999 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionsOfInvestments | Proceeds from Sale, Maturity and Collection of Investments | USD | 193.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecuritiesDebt | Proceeds from Sale of Debt Securities, Available-for-sale | USD | 18.90M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 1.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -133.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 118.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -538.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 5.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 300,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0001558370-25-001999 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 19.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 3.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 44.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 2.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 11.71 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 2,000 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-08 | 0001558370-24-007197 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 270,239 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 21.6 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 3.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 17.5 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 81.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 7.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 19.01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 81.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 7.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 19.01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 11.39 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 23.41 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 279.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 393.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.066 | 2024-01-23 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 141,459 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 304.49M | 2024-01-01 | 2024-03-31 | 2025 | Q3 | 10-Q | 2025-11-10 | 0001104659-25-108847 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 59.66M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 605,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 0 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 40.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001104659-26-024127 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 47.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation | Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation | shares | 492,956 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0001558370-25-001999 |
| us-gaap | WeightedAverageNumberOfSharesIssuedBasic | Weighted Average Number of Shares Issued, Basic | shares | 46.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 47.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001104659-26-124513 |